Skip to content
Companies

4C Medical Technologies

Transcatheter mitral valve replacement

Raised to date

$71.6M

of $166.1M offered across 2 Form D filings

Still open
$94.5M
Investors
80
Last filed
Mar 31, 2026

About

4C Medical Technologies, Inc. is a pioneering medical device company that specializes in developing innovative minimally invasive therapies for structural heart disease. The company's flagship focus is on treating mitral regurgitation (MR), a condition that affects heart function and can lead to severe complications if untreated.

4C Medical stands out for its commitment to providing treatment options for patients who are currently ineligible for conventional surgical interventions, particularly through the unique design of its AltaValve device.

Funding

  • EquityFiled Mar 31, 2026Form D/A
    $71.6M/ $166.1M
  • EquityFiled Mar 19, 2025Form D
    $71.6M/ $166.1M

Product

AltaValve

Medical Device

The AltaValve is an advanced transcatheter mitral valve replacement (TMVR) device designed specifically for patients suffering from mitral regurgitation. This innovative technology addresses the needs of patients who are not suitable candidates for traditional open-heart surgery, providing a crucial alternative therapy to manage their condition effectively.

  • Supra-annular positioning in the left atrium which enhances valve performance
  • Atrial-only fixation that preserves the integrity of the native mitral valve and left ventricle
  • Designed to mitigate complications associated with the complexities of the mitral annulus

Built for

Patients with moderate-to-severe or severe mitral regurgitation

People on file